In appellate briefings, defendants argued that a federal ruling striking down the state’s residency requirement for medical cannabis operators incorrectly cited the dormant commerce clause of the Constitution.
Toi Hutchinson, mostly drew plaudits and admiration from state industry leaders as she leaves her position as “Cannabis Czar” for Illinois Gov. J.B. Pritzker.
PharmaCann CEO Brett Novey thinks his company will have to go public to keep growing, that New York’s underground market is one his company’s more challenging issues, and that he expects to go shopping for dispensaries in Michigan to fill out his portfolio in that state.
Increasing cannabis demand has led to an increase in jobs in the legal cannabis industry, even though there are plenty of obstacles to hiring.
Massachusetts cannabis cultivators are dealing with a labor shortage, but the market for employers could get a lot tighter in 2022.
Illinois’ dispensary license holders will have to wait at least another month more as a result of new legal maneuvering over who will hear their cases creates yet more delays.
Maine’s medical marijuana workgroup soundly rejected medical cannabis tracking from METRC, condemning the company as a “data-selling conglomerate.”
The Ohio State Senate passed a cannabis bill that revises the state’s medical marijuana law, expands the list of qualifying conditions for medical marijuana, and consolidates regulation into a single agency.
The licenses of New York’s medical cannabis companies – the only ten in the state – are largely owned by multistate operators.
An Illinois judge affirmed a stay barring the state’s regulators from awarding 60 craft grow licenses by a Dec. 21 statutory deadline and set a hearing schedule that guarantees the licenses won’t be awarded until well into 2022.
